Literature DB >> 8548035

Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method.

K Hatanaka1, X A Li, K Masuda, C Yutani, A Yamamoto.   

Abstract

One-step fluorescein-conjugated polyclonal antibody technique has shown that C-reactive protein (CRP) was located only extracellularly in human atherosclerotic lesions. In this report a more sensitive streptavidin-biotin technique was applied to detect the localization of CRP in human atherosclerotic lesions. Immunohistochemical staining with polyclonal and monoclonal anti-human CRP antibodies both produced a brown color extracellularly in the necrotic lesions, and intracellularly in CD68+ foam cells. The latter suggests an uptake of CRP-lipid complexes by macrophages. The staining is human CRP-specific because it was eliminated by preabsorption of the monoclonal antibody with pure human CRP, or by substitution of the primary antibody with non-immune rabbit serum. By overlaid CRP-binding study, a positive stain was observed on intimal smooth muscle cells and foam cells, suggesting that they have CRP-binding sites unless the CRP-binding activity was generated de novo through the fixation procedure. Accordingly, it is hypothesized that CRP may facilitate the uptake of lipids by macrophages accumulating in atherosclerotic lesions. Further, CRP might participate in cytolysis, which enlarges the necrotic area, and/or in phagocytosis that scavenges the necrotic tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548035     DOI: 10.1111/j.1440-1827.1995.tb03515.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  12 in total

1.  C-reactive protein and atherogenesis: new insights from established animal models.

Authors:  Jan Torzewski
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

2.  Generation of C-reactive protein and complement components in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.

Authors:  Huijun Sun; Tomonari Koike; Tomonaga Ichikawa; Kinta Hatakeyama; Masashi Shiomi; Bo Zhang; Shuji Kitajima; Masatoshi Morimoto; Teruo Watanabe; Yujiro Asada; Yuqing E Chen; Jianglin Fan
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  Atherosclerosis-related functions of C-reactive protein.

Authors:  Alok Agrawal; David J Hammond; Sanjay K Singh
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-12-01

5.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 6.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

7.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

Review 8.  Ambient particle inhalation and the cardiovascular system: potential mechanisms.

Authors:  K Donaldson; V Stone; A Seaton; W MacNee
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

Review 9.  Recognition functions of pentameric C-reactive protein in cardiovascular disease.

Authors:  Alok Agrawal; Toh B Gang; Antonio E Rusiñol
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

10.  Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysms.

Authors:  Gustaf Tegler; Sergio Estrada; Håkan Hall; Anders Wanhainen; Martin Björck; Jens Sörensen; Gunnar Antoni
Journal:  Ups J Med Sci       Date:  2014-02-21       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.